Positive symptoms in first-episode psychosis patients experiencing low maternal care and stressful life events: A pilot study to explore the role of the COMT gene

Stress

Volumn 17, Issue 5, 2014, Pages 410-415

  Ira, Elisa ^a   De Santi, Katia ^a   Lasalvia, Antonio ^a   Bonetto, Chiara ^a   Zanatta, Gioia ^a   Cristofalo, Doriana ^a   Bertani, Mariaelena ^a   Bissoli, Sarah Saviana ^a   Riolo, Rossana ^b   Gardellin, Francesco ^b   Morandin, Idana ^b   Ramon, Luana ^b   Tansella, Michele ^a   Ruggeri, Mirella ^a   Tosato, Sarah ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Local Health Authority 6   (Italy)

Author keywords

COMT; First episode psychosis; Parental bonding; Stressful events

Indexed keywords

CATECHOL METHYLTRANSFERASE; COMT PROTEIN, HUMAN;

ADULT; AFFECTIVE PSYCHOSIS; ALLELE; ARTICLE; BLACK PERSON; CAUCASIAN; CHILD PARENT RELATION; DISEASE DURATION; DOPAMINE RELEASE; EARLY LIFE STRESS; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENETIC PREDISPOSITION; GENOTYPE; HEALTH CARE QUALITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MESOLIMBIC DOPAMINERGIC SYSTEM; NEGATIVE SYNDROME; PILOT STUDY; POSITIVE AND NEGATIVE SYNDROME SCALE; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; RACE DIFFERENCE; SCHIZOPHRENIA; SEX DIFFERENCE; GENETICS; LIFE EVENT; MATERNAL BEHAVIOR; MENTAL STRESS; MOTHER CHILD RELATION; PSYCHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

ADULT; ALLELES; CATECHOL O-METHYLTRANSFERASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIFE CHANGE EVENTS; MALE; MATERNAL BEHAVIOR; MOTHER-CHILD RELATIONS; PILOT PROJECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84906736005     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2014.948841     Document Type: Article

References (52)

1. Abi-Dargham A, Moore H. (2003). Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9(5): 404-16.
2. Akil M, Kolachana BS, Rothmond DA, Hyde TM, Weinberger DR, Kleinman JE. (2003). Catechol-O-methyltransferase genotype and dopamine regulation in the human brain. J Neurosci 23:2008-13.
3. Alexander N, Osinsky R, Mueller E, Schmitz A, Guenthert S, Kuepper Y, Henning J. (2011). Genetic variants within the dopaminergic system interact to modulate endocrine stress reactivity and recovery. Behav Brain Res 216(1):53-8.
4. Allen NC, Bagade S, McQueen MB, Ioannidis JP, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: The SzGene database. Nat Genet 40(7):827-34.
5. Barrowclough C, Tarrier N, Humphreys L, Ward J, Gregg, L, Andrews B. (2003). Self-esteem in schizophrenia: Relationships between selfevaluation, family attitudes, and symptomatology. J Abnorm Psychol 112(1):92-9.
6. Bebbington PE, Bhugra D, Brugha T, Singleton N, Farrell M, Jenkins R, Lewis G, Meltzer H. (2004). Psychosis, victimisation and childhood disadvantage: Evidence from the second British National Survey of Psychiatric Morbidity. Br J Psychiatr 185:220-6.
7. Belvederi Murri M, Pariante CM, Dazzan P, Hepgul N, Papadopoulos AS, Zunszain P, Di Forti M, et al. (2012). Hypothalamic-pituitaryadrenal axis and clinical symptoms in first-episode psychosis. Psychoneuroendocrinology 37(5):629-44.
8. Bentall RP, Wickham S, Shevlin M, Varese F. (2012). Do specific earlylife adversities lead to specific symptoms of psychosis? A study from the 2007 the Adult Psychiatric Morbidity Survey. Schizophr Bull 38(4):734-40.
9. Bertani M, Lasalvia A, Bonetto C, Tosato S, Cristofalo D, Bissoli S, De Santi K, et al. (2012). The influence of gender on clinical and social characteristics of patients at psychosis onset: A report from the Psychosis Incident Cohort Outcome Study (PICOS). Psychol Med 42(4):769-80.
10. Bertolino A, Caforio G, Blasi G, Rampino A, Nardini M, Weinberger DR, Dallapiccola B, Sinibaldi L, Douzgou S. (2007). COMT Val158Met polymorphism predicts negative symptoms response to treatment with olanzapine in schizophrenia. Schizophr Res 95(1-3): 253-5.
11. Boonstra N, Klaassen R, Sytema S, Marshall M, De Haan L, Wunderink L, Wiersma D. (2012). Duration of untreated psychosis and negative symptoms-a systematic review and meta-analysis of individual patient data. Schizophr Res 142(1-3):12-19.
12. Chambers JA, Power KG, Durham RC. (2004). Parental styles and longterm outcome following treatment for anxiety disorders. Clin Psychol Psychother 11(3):187-98.
13. Collip D, van Winkel R, Peerbooms O, Lataster T, Thewissen V, Lardinois M, Drukker M, et al. (2011). COMT Val158Met-stress interaction in psychosis: Role of background psychosis risk. CNS Neurosci Ther 17(6):612-19.
14. Davis KL, Kahn RS, Ko G, Davidson M. (1991). Dopamine in schizophrenia: A review and reconceptualization. Am J Psychiatry 148:1474-86.
15. Dickinson D, Elvevag B. (2009). Genes, cognition and brain through a COMT lens. Neuroscience 164:72-87.
16. Eells JB, Misler JA, Nikodem VM. (2006). Early postnatal isolation reduces dopamine levels, elevates dopamine turnover and specifically disrupts prepulse inhibition in Nurr1-null heterozygous mice. Neuroscience 140(4):1117-26.
17. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-22.
18. Engert V, Joober R, Meaney MJ, Hellhammer DH, Pruessner JC. (2009). Behavioral response to methylphenidate challenge: Influence of early life parental care. Dev Psychobiol 51(5):408-16.
19. Fan JB, Zhang CS, Gu NF, Li XW, Sun WW, Wang HY, Feng GY, et al. (2005). Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: A large-scale association study plus meta-analysis. Biol Psychiatr 57(2):139-44.
20. Fatemi SH, Folsom TD, Reutiman TJ, Novak J, Engel RH. (2012). Comparative gene expression study of the chronic exposure to clozapine and haloperidol in rat frontal cortex. Schizophr Res 134(2-3):211-18.
21. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE. (2001). A cognitive model of the positive symptoms of psychosis. Psychol Med 31(2):189-95.
22. Glatt SJ, Faraone SV, Tsuang MT. (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. Am J Psychiatr 160(3):469-76.
23. He Q, Xue G, Chen C, Lu ZL, Chen C, Lei X. (2012). COMT Val158Met polymorphism interacts with stressful life events and parental warmth to influence decision making. Sci Rep 2:677.
24. Holmes TH, Rahe RH. (1967). The social readjustment rating scale. J Psychosom Res 11(2):213-18.
25. Huppertz-Kessler CJ, Poeschl J, Hertel R, Unsicker K, Schenkel J. (2012). Effects of a new postnatal stress model on monoaminergic neurotransmitters in rat brains. Brain Dev 34(4):274-9.
26. Ira E, Zanoni M, Ruggeri M, Dazzan P, Tosato S. (2013). COMT, neuropsychological function and brain structure in schizophrenia: A systematic review and neurobiological interpretation. J Psychiatry Neurosci 38(6):366-80.
27. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. (1992). Schizophrenia: Manifestations, incidence and course in different cultures. A World Health Organization tencountry study. Psychol Med Monograph Supplement 20:1-97.
28. Kay SR, Fiszbein A, Opler LA. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2): 261-76.
29. Laruelle M, Abi-Dargham A. (1999). Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies. J Psychopharmacol 13:358-71.
30. Lasalvia A, Tosato S, Brambilla P, Bertani M, Bonetto C, Cristofalo D, Bissoli S, et al. (2012). A multisite study of clinical, social and biological characteristics, patterns of care and predictors of outcome in first-episode psychosis. Background, methodology and overview of the patient sample. Epidemiol Paychiatr Sci 21(3):281-303.
31. Lataster J, Myin-Germeys I, Lieb R, Wittchen HU, van Os J. (2012). Adversity and psychosis: A 10-year prospective study investigating synergism between early and recent adversity in psychosis. Acta Psychiatr Scand 125(5):388-99.
32. Melas PA, Rogdaki M, Ösby U, Schalling M, Lavebratt C, Ekström TJ. (2012). Epigenetic aberrations in leukocytes of patients with schizophrenia: Association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J 26(6):2712-8.
33. Mizrahi R, Addington J, Rusjan PM, Suridjan I, Ng A, Boileau I, Pruessner JC, et al. (2012). Increased stress-induced dopamine release in psychosis. Biol Psychiatr 71(6):561-7.
34. Molero P, Ortuño F, Zalacain M, Patiño-Garća A. (2007). Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: Influence on the severity of psychotic symptoms and on the response to neuroleptic treatment. Pharmacogenomics J 7(6):418-26.
35. Morrison AP, Frame L, Larkin W. (2003). Relationships between trauma and psychosis: A review and integration. Br J Clin Psychol 42(Pt 4): 331-53.
36. Murphy E, Wickramaratne P, Weissman M. (2010). The stability of parental bonding reports: A 20-year follow-up. J Affect Didord 125(1-3):307-15.
37. Parker G. (1983). Parental overprotection: a risk factor in psychosocial development. New York: Grune & Stratton.
38. Parker G, Tupling H, Brown LB. (1979). A parental bonding instrument. Br J Med Psychol 52:1-10.
39. Paykel ES, Prusoff BA, Uhlenhuth EH. (1971). Scaling of life events. Arch Gen Psvchiatrv 25:340-7.
40. Peerbooms O, Rutten BP, Collip D, Lardinois M, Lataster T, Thewissen V, Rad SM, et al. (2012). Evidence that interactive effects of COMT and MTHFR moderate psychotic response to environmental stress. Acta Psychiatr Scand 125(3):247-56.
41. Pruessner JC, Champagne F, Meaney MJ, Dagher A. (2004). Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: A positron emission tomography study using [11C] raclopride. J Neurosci 24(11):2825-31.
42. Sakado K, Sato T, Uehara T, Sakado M, Someya T. (1999). Perceived parenting pattern and response to antidepressants in patients with major depression. J Affect Disord 52(1-3):59-66.
43. Savitz J, Solms M, Ramesar R. (2006). The molecular genetics of cognition: Dopamine, COMT and BDNF. Genes Brain Behav 5: 311-28.
44. Simons CJ, Wichers M, Derom C, Thiery E, Myin-Germeys I, Krabbendam L, van Os J. (2009). Subtle gene-environment interactions driving paranoia in daily life. Genes Brain Behav 8(1):5-12.
45. Stefanis NC, Henquet C, Avramopoulos D, Smyrnis N, Evdokimidis I, Myin-Germeys I, Stefanis CN, Van Os J. (2007). COMT Val158Met moderation of stress-induced psychosis. Psychol Med 37(11):1651-6.
46. Struglia F, Stratta P, Gianfelice D, Pacifico R, Riccardi I, Rossi A. (2011). Decision-making impairment in schizophrenia: Relationships with positive symptomatology. Neurosci Lett 502(2):80-3.
47. Tessner KD, Mittal V, Walker EF. (2011). Longitudinal study of stressful life events and daily stressors among adolescents at high risk for psychotic disorders. Schizophr Bull 37(2):432-41.
48. Tosato S, Bonetto C, Di Forti M, Collier D, Cristofalo D, Bertani M, Zanoni M, et al. (2011). Effect of COMT genotype on aggressive behaviour in a community cohort of schizophrenic patients. Neurosci Lett 495(1):17-21.
49. Tosato S, Lasalvia A, Bonetto C, Mazzoncini R, Cristofalo D, De Santi, K, Bertani M, et al. (2013). The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS). J Psychiatr Res 47:438-44.
50. Turner HM, Rose KS, Cooper MJ. (2005). Schema and parental bonding in overweight and nonoverweight female adolescents. Int J Obes (Lond) 29(4):381-7.
51. Van Os J, Kenis G, Rutten BPF. (2010). The environment and schizophrenia. Nature 468:203-12.
52. van Winkel R, Henquet C, Rosa A, Papiol S, Fananás L, De Hert M, Peuskens J, et al. (2008). Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: An experience-sampling study. Am J Med Genet B Neuropsychiatr Genet 147B(1):10-17.